Global Healthcare Analyst

Tina Banerjee

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sonendo-inc" target="_blank" data-smartkarma-citation="entities:34589:1" rel="noopener">Sonendo (SONX US) </a>shares debuted on the New York Stock Exchange on October 29, 2021. Shares are currently trading below the IPO price. Sonendo priced its $84 million IPO at $12 per share, well below the earlier announced range of $15–17.</li>
<li>Sonendo’s GentleWave system is an innovative technology for endodontic treatment, commonly known as root canal therapy. Increasing installed base of GentleWave consoles and their corresponding recurring utilization are generating a stream of predictable, recurring revenue from single-use procedure instrument.</li>
<li>Business scale up and expansion of marketing team will drive the long-term growth potential of the company.</li>
</ul>



Sonendo (SONX US) shares debuted on the New York Stock Exchange on October 29, 2021. Shares are currently trading below the IPO price. Sonendo priced its $84 million IPO at $12 per share, well below the earlier announced range of $15–17.
Sonendo’s GentleWave system is an innovative technology for endodontic treatment, commonly known as root canal therapy. Increasing installed base of GentleWave consoles and their corresponding recurring utilization are generating a stream of predictable, recurring revenue from single-use procedure instrument.
Business scale up and expansion of marketing team will drive the long-term growth potential of the company.


Sonendo (SONX US) IPO Review: Innovative Technology Platform, But Execution Is the Key

United States

Sonendo Inc. develops dental surgery equipment. The Company specializes in novel technology for the cleaning of root canals. Sonendo operates out of Laguna Hills, California.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Sonendo (SONX US) IPO Review: Innovative Technology Platform, But Execution Is the Key

The insight has analyzed Sonendo's disruptive technology for root canal therapy. However, the company's commercialization success and sales team...

Tina Banerjee